1 University of Michigan Rogel Cancer Center; Stanford Cancer Institute; Huntsman Cancer Institute at the University of Utah; Vanderbilt-Ingram Cancer Center; University of Wisconsin Carbone Cancer Center; Fox Chase Cancer Center; Yale Cancer Center/Smilow Cancer Hospital; University of Alabama at Birmingham Comprehensive Cancer Center; Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute; Memorial Sloan Kettering Cancer Center; Patient advocate; Fred & Pamela Buffett Cancer Center; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute; UCSF Helen Diller Family Comprehensive Cancer Center; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Massachusetts General Hospital Cancer Center; City of Hope National Medical Center; Robert H. Lurie Comprehensive Cancer Center of Northwestern University; Mayo Clinic Cancer Center; The University of Texas MD Anderson Cancer Center; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; Roswell Park Comprehensive Cancer Cancer Center; St. Jude Children's Research Hospital/The University of Tennessee Health Science Center; University of Colorado Cancer Center; Dana-Farber/Brigham and Women's Cancer Center; Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance; Moffitt Cancer Center; and National Comprehensive Cancer Network.
The NCCN Guidelines for Small Cell Lung Cancer (SCLC) address all aspects of disease management. These NCCN Guidelines Insights focus on recent updates to the NCCN Guidelines for SCLC regarding immunotherapy, systemic therapy, and radiation therapy. For the 2018 update, new sections were added on “Signs and Symptoms of SCLC” and “Principles of Pathologic Review.”
Provided content development and/or authorship assistance.